Understanding drug‐likeness
暂无分享,去创建一个
Tudor I. Oprea | Anwar Rayan | Oleg Ursu | Amiram Goldblum | T. Oprea | A. Rayan | A. Goldblum | O. Ursu
[1] Jean-Loup Faulon,et al. The Signature Molecular Descriptor. 1. Using Extended Valence Sequences in QSAR and QSPR Studies , 2003, J. Chem. Inf. Comput. Sci..
[2] Robert D. Carr,et al. The Signature Molecular Descriptor. 4. Canonizing Molecules Using Extended Valence Sequences , 2004, J. Chem. Inf. Model..
[3] Mukund S. Chorghade. Drug Discovery and Development: Drug Discovery , 2006 .
[4] Robert Bywater,et al. Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds , 2000, J. Chem. Inf. Comput. Sci..
[5] A. Rayan,et al. Exploring the conformational space of cyclic peptides by a stochastic search method. , 2004, Journal of molecular graphics & modelling.
[6] Tudor I. Oprea,et al. Scaffold Topologies. 1. Exhaustive Enumeration up to Eight Rings , 2008, J. Chem. Inf. Model..
[7] C. Ganellin,et al. Analogue-based Drug Discovery , 2006 .
[8] Alessandro Pedretti,et al. Assessing drug-likeness--what are we missing? , 2008, Drug discovery today.
[9] Ajay,et al. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.
[10] A. Leo. CALCULATING LOG POCT FROM STRUCTURES , 1993 .
[11] Gunnar Rätsch,et al. Classifying 'Drug-likeness' with Kernel-Based Learning Methods , 2005, J. Chem. Inf. Model..
[12] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[13] Tudor I. Oprea,et al. Integrating virtual screening in lead discovery. , 2004, Current opinion in chemical biology.
[14] S. Hitchcock,et al. Blood-brain barrier permeability considerations for CNS-targeted compound library design. , 2008, Current opinion in chemical biology.
[15] Tudor I. Oprea,et al. Rapid Evaluation of Synthetic and Molecular Complexity for in Silico Chemistry , 2005, J. Chem. Inf. Model..
[16] Y. Martin,et al. A bioavailability score. , 2005, Journal of medicinal chemistry.
[17] Gang Chen,et al. A New Rapid and Effective Chemistry Space Filter in Recognizing a Druglike Database , 2005, J. Chem. Inf. Model..
[18] Markus Wagener,et al. Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features , 2000, J. Chem. Inf. Comput. Sci..
[19] Igor V. Pletnev,et al. Drug Discovery Using Support Vector Machines. The Case Studies of Drug-likeness, Agrochemical-likeness, and Enzyme Inhibition Predictions , 2003, J. Chem. Inf. Comput. Sci..
[20] S. Anzali,et al. Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). , 2001, Journal of medicinal chemistry.
[21] Fabio Zuccotto,et al. Pharmacophore Features Distributions in Different Classes of Compounds , 2003, J. Chem. Inf. Comput. Sci..
[22] C E Berkoff,et al. Substructural analysis. A novel approach to the problem of drug design. , 1974, Journal of medicinal chemistry.
[23] Tingjun Hou,et al. ADME Evaluation in Drug Discovery, 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules? , 2007, J. Chem. Inf. Model..
[24] W. Sneader. Drug prototypes and their exploitation , 1996 .
[25] Tudor I. Oprea,et al. Model-Free Drug-Likeness from Fragments , 2010, J. Chem. Inf. Model..
[26] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[27] H. Kubinyi. Drug research: myths, hype and reality , 2003, Nature Reviews Drug Discovery.
[28] C. Ganellin,et al. Analogue-based Drug Discovery: FISCHER: ANALOGUE-BASED DRUG DISCOVERY O-BK , 2006 .
[29] Scott Boyer,et al. Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data , 2007, J. Comput. Aided Mol. Des..
[30] Tudor I. Oprea,et al. Scaffold Topologies. 2. Analysis of Chemical Databases , 2008, J. Chem. Inf. Model..
[31] J. Wang,et al. Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds. , 1999, Journal of combinatorial chemistry.
[32] Tudor I. Oprea,et al. Novel chemical space exploration via natural products. , 2009, Journal of medicinal chemistry.
[33] Christopher J. C. Burges,et al. A Tutorial on Support Vector Machines for Pattern Recognition , 1998, Data Mining and Knowledge Discovery.
[34] P. Leeson,et al. A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.
[35] Tudor I. Oprea,et al. Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.
[36] Tudor I. Oprea,et al. Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..
[37] György M. Keserü,et al. The influence of lead discovery strategies on the properties of drug candidates , 2009, Nature Reviews Drug Discovery.
[38] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[39] P. Willett,et al. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.
[40] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[41] D Schwartzman. "Innovation in the Pharmaceutical Industry". , 1978, British medical journal.
[42] Phillip Jeffrey,et al. The Practice of Medicinal Chemistry , 2004 .
[43] Amiram Goldblum,et al. Predicting Oral Druglikeness by Iterative Stochastic Elimination , 2010, J. Chem. Inf. Model..
[44] Ian A. Watson,et al. Characteristic physical properties and structural fragments of marketed oral drugs. , 2004, Journal of medicinal chemistry.
[45] Tudor I. Oprea,et al. Transporter‐Mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target , 2010, Molecular informatics.
[46] Cele Abad-Zapatero,et al. A sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond. , 2007, Drug discovery today.
[47] J. Topliss,et al. QSAR model for drug human oral bioavailability. , 2000, Journal of medicinal chemistry.
[48] Gerd Folkers,et al. Tautomerism in Computer‐Aided Drug Design , 2003, Journal of receptor and signal transduction research.
[49] D. E. Clark. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.
[50] Mark A. Murcko,et al. Virtual screening : an overview , 1998 .
[51] M. Stone,et al. Statistical Thinking and Technique for QSAR and Related Studies. Part 1. General Theory , 1994 .
[52] Lorenz C. Blum,et al. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. , 2009, Journal of the American Chemical Society.
[53] J. Proudfoot. Drugs, leads, and drug-likeness: an analysis of some recently launched drugs. , 2002, Bioorganic & medicinal chemistry letters.
[54] Anton J. Hopfinger,et al. Predicting Caco-2 Cell Permeation Coefficients of Organic Molecules Using Membrane-Interaction QSAR Analysis. , 2002 .
[55] Shayne C. Gad,et al. Drug Discovery Handbook , 1994 .
[56] Gregg D. Wilensky,et al. Neural Network Studies , 1993 .
[57] Jun Xu,et al. Drug-like Index: A New Approach To Measure Drug-like Compounds and Their Diversity , 2000, J. Chem. Inf. Comput. Sci..
[58] Ross D. King,et al. Drugs and Drug-Like Compounds: Discriminating Approved Pharmaceuticals from Screening-Library Compounds , 2009, PRIB.
[59] Philip Jonathan,et al. Statistical thinking and technique for QSAR and related studies. Part I: General theory , 1993 .
[60] I. Muegge,et al. Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.
[61] Michael Williams,et al. Drug Discovery and Development , 1987, Humana Press.
[62] Andreas Bender,et al. A Large Descriptor Set and a Probabilistic Kernel-Based Classifier Significantly Improve Druglikeness Classification , 2007, J. Chem. Inf. Model..
[63] Michael C. Hutter,et al. Gradual in Silico Filtering for Druglike Substances , 2008, J. Chem. Inf. Model..
[64] Hans Matter,et al. Computational Medicinal Chemistry for Drug Discovery , 2004 .
[65] G. Samuelsson. Drugs of natural origin : a textbook of pharmacognosy , 1999 .
[66] Santiago Vilar,et al. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. , 2008, Current topics in medicinal chemistry.
[67] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[68] Dan C. Fara,et al. Lead-like, drug-like or “Pub-like”: how different are they? , 2007, J. Comput. Aided Mol. Des..
[69] Pedro Cuatrecasas,et al. Drug discovery in jeopardy. , 2006, The Journal of clinical investigation.
[70] Yi Han,et al. Predicting Caco-2 Cell Permeation Coefficients of Organic Molecules Using Membrane-Interaction QSAR Analysis , 2002, J. Chem. Inf. Comput. Sci..
[71] L. Hodes,et al. A statistical-heuristic methods for automated selection of drugs for screening. , 1977, Journal of medicinal chemistry.
[72] John Bradshaw,et al. Identification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms , 1998, J. Chem. Inf. Comput. Sci..
[73] H. van de Waterbeemd,et al. ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.
[74] Gordon M. Crippen,et al. Use of Classification Regression Tree in Predicting Oral Absorption in Humans , 2004, J. Chem. Inf. Model..
[75] T. Ritchie,et al. The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.
[76] Yutaka Endo,et al. Development of a Method for Evaluating Drug-Likeness and Ease of Synthesis Using a Data Set in Which Compounds Are Assigned Scores Based on Chemists' Intuition , 2003, J. Chem. Inf. Comput. Sci..
[77] Andreas Bender,et al. Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..
[78] Yuichi Nagahara,et al. Are There Differences between Launched Drugs, Clinical Candidates, and Commercially Available Compounds? , 2010, J. Chem. Inf. Model..
[79] P. Leeson,et al. The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.
[80] Igor V. Tetko,et al. Neural network studies, 1. Comparison of overfitting and overtraining , 1995, J. Chem. Inf. Comput. Sci..
[81] Tudor I. Oprea,et al. Strategies for compound selection. , 2004, Current drug discovery technologies.
[82] Tingjun Hou,et al. ADME evaluation in drug discovery , 2002, Journal of molecular modeling.
[83] P. Andrews,et al. Functional group contributions to drug-receptor interactions. , 1984, Journal of medicinal chemistry.
[84] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[85] I. Tetko,et al. Application of ALOGPS to predict 1-octanol/water distribution coefficients, logP, and logD, of AstraZeneca in-house database. , 2004, Journal of pharmaceutical sciences.
[86] P. Verhoest,et al. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. , 2010, ACS chemical neuroscience.
[87] Louis Hodes,et al. A STATISTICAL-HEURISTIC METHOD FOR AUTOMATED SELECTION OF DRUGS FOR SCREENING , 1977 .
[88] John G. Topliss,et al. QSAR Model for Drug Human Oral Bioavailability1 , 2000 .
[89] Roy J. Vaz,et al. Antitargets : prediction and prevention of drug side effects , 2008 .
[90] D. E. Clark,et al. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.
[91] Tudor I. Oprea,et al. Chemical space navigation in lead discovery. , 2002, Current opinion in chemical biology.
[92] C. Humblet,et al. Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.
[93] Shayne Cox Gad,et al. Drug Discovery Handbook: Gad/Drug Discovery Handbook , 2005 .
[94] Tudor I. Oprea,et al. The Design of Leadlike Combinatorial Libraries. , 1999, Angewandte Chemie.
[95] Andreas Bender,et al. Molecular Similarity Searching Using Atom Environments, Information-Based Feature Selection, and a Naïve Bayesian Classifier , 2004, J. Chem. Inf. Model..
[96] Bernd Beck,et al. Descriptors, physical properties, and drug-likeness. , 2002, Journal of medicinal chemistry.
[97] Douglas M. Hawkins,et al. The Problem of Overfitting , 2004, J. Chem. Inf. Model..
[98] Amiram Goldblum,et al. A stochastic algorithm for global optimization and for best populations: A test case of side chains in proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[99] Jürgen Drews,et al. Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D , 1998 .
[100] K. Luthman,et al. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. , 1998, Journal of medicinal chemistry.
[101] Hugo Kubinyi,et al. From Narcosis to Hyperspace: The History of QSAR , 2002 .
[102] Jean-Loup Faulon,et al. The Signature Molecular Descriptor. 2. Enumerating Molecules from Their Extended Valence Sequences , 2003, J. Chem. Inf. Comput. Sci..
[103] G. Grisetti,et al. Further Reading , 1984, IEEE Spectrum.
[104] I. Muegge. Selection criteria for drug‐like compounds , 2003, Medicinal research reviews.
[105] G de Stevens,et al. Serendipity and structured research in drug discovery. , 1986, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[106] Christel A. S. Bergström,et al. Absorption classification of oral drugs based on molecular surface properties. , 2003, Journal of medicinal chemistry.
[107] David Weininger,et al. Combinatorics of Small Molecular Structures , 2002 .
[108] Tudor I. Oprea,et al. Chemical information management in drug discovery: optimizing the computational and combinatorial chemistry interfaces. , 2000, Journal of Molecular Graphics and Modelling.
[109] Emanuele Perola,et al. An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs. , 2010, Journal of medicinal chemistry.
[110] Tudor I. Oprea. Current trends in lead discovery: Are we looking for the appropriate properties? , 2002, J. Comput. Aided Mol. Des..